Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Transplantation of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (ASC) in Patients With Critical Limb Ischemia.

NCT03968198 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03968198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03968198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Transplantation of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (ASC) in Patients With Critical Limb Ischemia.
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Terminated
Start date
March 4, 2020
Completion date
March 10, 2023
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia and peripheral artery disease